By integrating resources such as registration, medical, Phase I center, and PK testing lab, CR Medicon is able to complete high-quality new drug early phase research.
Integrated Services & Advantages
Create a collaborative and rapid advancement plan through all steps, from pre-IND meetings, protocol drafting, pre-IRB review and IND filing, to the first subject recruited into the test group.
Partnered with multiple Phase I Centers in China, we conduct early clinical studies with various complexities and indications, with rapid trial initiation and rapid subject enrollment.
Our Phase I Center in Baltimore, USA, provides early-stage research in new drug development towards US FDA submission.
Fully meeting all FDA GLP requirements, CR Medicon's own biological sample analysis and testing lab enables rapid method development. Operating with high-sensitivity analytical instruments, we fully meet the requirements of new drug and metabolite detection and performs rapid analysis of each sample batch.
Our one-stop service system enables effective collaboration of multiple functional teams to accelerate project progress